Please select the option that best describes you:
Do you routinely recommend prophylactic cranial irradiation for stage I small-cell lung cancers treated with lobectomy and adjuvant chemotherapy?
Does tumor size, age, or performance status play a role in your decision-making?
Answer from: Radiation Oncologist at Community Practice
PCI was 'associated' with better long-term survival even in stage 1, and age and size factors do not seem to matter. However, as the information gets divided, fewer patients fall into each cohort.A recent study published in the JCO, analyzing over 1,000 patients in the NCDB, found that thoracic radi...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Great question. While we attempt to determine the benefit of PCI in the modern MRI era for limited-stage SCLC (MAVERICK trial), for a patient in this scenario, I would present the choice of PCI or undergoing surveillance MRI every three months. However, pending the results of MAVERICK, the current s...
Comments
Radiation Oncologist at Quillen VA Medical Center
Has MAVERICK been open since 2016? I mostly agree ...
Has MAVERICK been open since 2016? I mostly agree ...
Radiation Oncologist at Northeast Radiation Oncology
Most patients do decline PCI after I present the c...
Most patients do decline PCI after I present the c...
Radiation Oncologist at Quillen VA Medical Center
When there's no absolute clarity, a lot relies on ...
When there's no absolute clarity, a lot relies on ...
Radiation Oncologist at Mallory Radiotherapy, PLLC
I agree. It is frustrating to see cases presented ...
I agree. It is frustrating to see cases presented ...
Answer from: Radiation Oncologist at Community Practice
All physicians have their personal biases, especially evident in discussions about PCI, but it's crucial not to let these biases obscure our judgment in understanding and treating cases where different approaches might be warranted.In the context of stage I SCLC treated with resection and adjuvant c...